CD8A and metabolic dysfunction-associated steatotic liver disease: The 45% HFD recapitulates the liver pathology, metabolic syndrome and disease pathogenesis observed in human MASLD with advanced fibrosis, where we also observed systemic CD8 T cell hyperfunction (Figure S3).